Showing results (551-560 of 558) with videos related to
Sort By:
Pageof 56
You have reached the last page of results.This site can display upto 558 results.
European Urology|January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part ISusanne Krege, Jörg Beyer, Rainer Souchon, et al.Clinical and Experimental Rheumatology|August 4, 2017
Timing of onset affects arthritis presentation pattern in antisyntethase syndromeMiguel A González-Gay, Carlomaurizio Montecucco, Albert Selva-O'Callaghan, et al.ESMO Open|November 16, 2016
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016Christian Dittrich, Michael Kosty, Svetlana Jezdic, et al.Journal of Clinical Medicine|November 23, 2019
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time CourseLorenzo Cavagna, Ernesto Trallero-Araguás, Federica Meloni, et al.European Urology|November 23, 2019
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines CommitteesJ Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.European Journal of Cancer (Oxford, England : 1990)|April 1, 2023
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.European Urology|December 9, 2022
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022Silke Gillessen, Alberto Bossi, Ian D Davis, et al.European Urology|October 11, 2024
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)Silke Gillessen, Fabio Turco, Ian D Davis, et al.Pageof 56